Genmab to acquire Merus for $8 billion
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
Proposed acquisition adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio
A Post Graduate in Science faculty and has a wide experience spanning over 35 years in the field of manufacturing Bulk Drugs and Active Pharmaceutical Intermediaries
The acquisition positions ACL Digital as an end-to-end provider of global clinical research and data CRO solutions
Sanofi Ventures drives innovation through leading and participating in private financing rounds for pioneering healthcare companies
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
Harmonisation of listing structure requires a direct listing of AstraZeneca shares on the NYSE in place of existing US ADRs
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
Corning and SGD Pharma formed JV in June 2023 to expand pharmaceutical manufacturing in India
Subscribe To Our Newsletter & Stay Updated